Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

21 Mar 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated March 21, 2022 titled ‘Zydus receives Prior Approval Supplement (PAS) approval from USFDA for Mycophenolate Mofetil for Injection USP’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1906.25
Dr. Reddys Labs. 1379.75
Cipla 1404.20
Lupin 2022.95
Zydus Lifesciences 1210.50
View more..